HAM: Medium Dose of Cytarabine and Mitoxantrone
Study Details
Study Description
Brief Summary
By observation of the inpatients in shenzhen people's hospital,research the curative effect of the two chemotherapy schemes on AML-High dose of cytarabine and HAM.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The patients of AML in shenzhen people's hospital were randomly divided into two therapy groups.One group was treated by High dose of cytarabine ,and the other was HAM.Evaluate the two chemotherapy schemes by bone marrow suppression time and patient survival time.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
high dose of cytarabine high dose of cytarabine |
Device: Flow Cytometer
high dose
Drug: Mitoxantrone
high dose
Drug: Cytarabine
high dose
|
HAM medium dose of cytarabine and mitoxantrone |
Device: Flow Cytometer
high dose
Drug: Mitoxantrone
high dose
Drug: Cytarabine
high dose
|
Outcome Measures
Primary Outcome Measures
- bone marrow suppression time [one month]
time of agranulocytosis
- patient survival time [three years]
disease free survival
Eligibility Criteria
Criteria
Inclusion Criteria:
people diagnosed as AML
Exclusion Criteria:
- acute promyeloytic leukemia
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shenzhen | Shenzhen | Guangdong | China | 518000 |
Sponsors and Collaborators
- Shenzhen People's Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- YLi